Cardiol Therapeutics Inc. (CRDL) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cardiol Therapeutics Inc.

    NASDAQ: CRDL · Real-Time Price · USD
    1.07
    0.02 (1.90%)
    At close: Oct 03, 2025, 3:59 PM
    1.07
    -0.01%
    After-hours: Oct 03, 2025, 07:53 PM EDT

    Cardiol Therapeutics Income Statement

    Financials in CAD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 78.76K
    Cost of Revenue
    		 n/a 248.35K 219.91K n/a
    Gross Profit
    		 n/a -248.35K -219.91K 78.76K
    Operating Income
    		 -40.28M -29.79M -50.34M -45.47M
    Interest Income
    		 n/a 2.04K 1.24M 106K
    Pretax Income
    		 -36.68M -28.13M -30.93M -31.64M
    Net Income
    		 -36.68M -28.13M -30.93M -31.64M
    Selling & General & Admin
    		 26.26M 15.56M 22.37M 27.87M
    Research & Development
    		 14.01M 14.22M 18.96M 10.87M
    Other Expenses
    		 n/a 0.00 164.44K 112.23K
    Operating Expenses
    		 40.28M 29.79M 41.34M 38.74M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 40.28M 29.79M 41.34M 38.74M
    Income Tax Expense
    		 n/a n/a -10.24M -6.91M
    Shares Outstanding (Basic)
    		 71.57M 64.46M 62.51M 43.22M
    Shares Outstanding (Diluted)
    		 71.57M 64.46M 62.51M 43.22M
    EPS (Basic)
    		 -0.51 -0.44 -0.49 -0.73
    EPS (Diluted)
    		 -0.51 -0.44 -0.49 -0.73
    EBITDA
    		 -40.11M -29.59M -41.16M -38.44M
    EBIT
    		 -40.28M -29.79M -41.34M -38.66M
    Depreciation & Amortization
    		 162.1K 195.26K 219.91K 220.42K

    Add to Watchlist